Bio-Rad Laboratories Overview
- Year Founded
-
1952

- Status
-
Public
- Employees
-
8,030

- Stock Symbol
-
BIO

- Investments
-
33
- Share Price
-
$342.13
- (As of Friday Closing)
Bio-Rad Laboratories General Information
Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact Information
Website
www.bio-rad.comCorporate Office
- 1000 Alfred Nobel Drive
- Hercules, CA 94547
- United States
Corporate Office
- 1000 Alfred Nobel Drive
- Hercules, CA 94547
- United States
Bio-Rad Laboratories Stock Performance
As of 07-Feb-2025, Bio-Rad Laboratories’s stock price is $342.13. Its current market cap is $9.6B with 28M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$342.13 | $345.41 | $262.12 - $387.99 | $9.6B | 28M | 174K | -$27.74 |
Bio-Rad Laboratories Financials Summary
As of 30-Sep-2024, Bio-Rad Laboratories has a trailing 12-month revenue of $2.58B.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 9,061,734 | 9,045,770 | 11,989,245 | 21,327,419 |
Revenue | 2,580,209 | 2,671,262 | 2,802,249 | 2,922,545 |
EBITDA | (889,415) | (755,665) | (4,586,859) | 5,569,306 |
Net Income | (778,690) | (637,324) | (3,627,535) | 4,254,257 |
Total Assets | 10,603,472 | 12,299,070 | 13,501,666 | 17,799,393 |
Total Debt | 1,388,115 | 1,405,443 | 1,388,098 | 223,376 |
Bio-Rad Laboratories Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Bio-Rad Laboratories Comparisons
Industry
Financing
Details
Bio-Rad Laboratories Competitors (20)
One of Bio-Rad Laboratories’s 20 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Illumina | Formerly VC-backed | San Diego, CA | ||||
Sysmex (Diagnostic Equipment) | Corporation | Kobe, Japan | ||||
QuidelOrtho | Corporation | San Diego, CA | ||||
BioMérieux (Diagnostic Equipment) | Formerly PE-Backed | Marcy-l'Etoile, France | ||||
AliveDx | Formerly VC-backed | Eysins, Switzerland |
Bio-Rad Laboratories Patents
Bio-Rad Laboratories Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250043362-A1 | Selective digital multiplexing | Pending | 04-Aug-2023 | ||
US-20240384335-A1 | Linkage assay | Pending | 19-May-2023 | ||
US-20240367161-A1 | Multimodal chromatography resins with anionic and cationic ligands | Pending | 05-May-2023 | ||
US-20240367143-A1 | Polymer-hydroxyapatite composite membranes | Pending | 02-May-2023 | ||
US-20240367141-A1 | Particulate hydroxyapatite (ha) substrates and uses thereof | Pending | 02-May-2023 | B01J20/282 |
Bio-Rad Laboratories Signals
Bio-Rad Laboratories Investments & Acquisitions (33)
Bio-Rad Laboratories’s most recent deal was a Later Stage VC with Geneoscopy for . The deal was made on 08-Jan-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Geneoscopy | 08-Jan-2025 | Later Stage VC | Diagnostic Equipment | ||
OncoCyte | 02-Oct-2024 | PIPE | Diagnostic Equipment | ||
Genetic Analysis | 01-Jul-2024 | PIPE | Laboratory Services (Healthcare) | ||
OncoCyte | 15-Apr-2024 | PIPE | Diagnostic Equipment | ||
Curiosity Diagnostics | 03-Aug-2022 | Merger/Acquisition | Diagnostic Equipment |
Bio-Rad Laboratories ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
16.77 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile

Pharmaceuticals
Industry
of 853
Rank
Percentile

Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile

Bio-Rad Laboratories Exits (2)
Bio-Rad Laboratories’s most recent exit was on 01-Feb-2017 from Propel Labs (Flow cytometry Platform). The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Propel Labs (Flow cytometry Platform) | 01-Feb-2017 | Completed |
|
||
Cellular Life Sciences | 01-Jan-1970 | Merger/Acquisition | Completed |
Affiliates
Subsidiaries (4)
Name | Industry | Location | Year Founded |
---|---|---|---|
ODx | Inverness, United Kingdom | 2016 | |
Exact Diagnostics | Fort Worth, TX | 2015 | |
GnuBIO | Cambridge, MA | 2009 | |
Bio-Rad Antibodies | Kidlington, United Kingdom | 1952 |
Bio-Rad Laboratories FAQs
-
When was Bio-Rad Laboratories founded?
Bio-Rad Laboratories was founded in 1952.
-
Where is Bio-Rad Laboratories headquartered?
Bio-Rad Laboratories is headquartered in Hercules, CA.
-
What is the size of Bio-Rad Laboratories?
Bio-Rad Laboratories has 8,030 total employees.
-
What industry is Bio-Rad Laboratories in?
Bio-Rad Laboratories’s primary industry is Diagnostic Equipment.
-
Is Bio-Rad Laboratories a private or public company?
Bio-Rad Laboratories is a Public company.
-
What is Bio-Rad Laboratories’s stock symbol?
The ticker symbol for Bio-Rad Laboratories is BIO.
-
What is the current stock price of Bio-Rad Laboratories?
As of 07-Feb-2025 the stock price of Bio-Rad Laboratories is $342.13.
-
What is the current market cap of Bio-Rad Laboratories?
The current market capitalization of Bio-Rad Laboratories is $9.6B.
-
What is Bio-Rad Laboratories’s current revenue?
The trailing twelve month revenue for Bio-Rad Laboratories is $2.58B.
-
Who are Bio-Rad Laboratories’s competitors?
Illumina, Sysmex (Diagnostic Equipment), QuidelOrtho, BioMérieux (Diagnostic Equipment), and AliveDx are some of the 20 competitors of Bio-Rad Laboratories.
-
What is Bio-Rad Laboratories’s annual earnings per share (EPS)?
Bio-Rad Laboratories’s EPS for 12 months was -$27.74.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »